Intentar ORO - Gratis
Advancing ADHD Care through integrative approach
Chronicle Pharmabiz
|November 27, 2025
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental diseases in children and adolescents.
It is usually diagnosed in childhood and frequently lasts into adulthood. Children who experience ADHD may be difficult to concentrate, behave impulsively and without self-control, or be very active. Boys are two times more likely to be affected than girls.
For around 30-50 per cent of people with ADHD, symptoms persist through adolescence and into adulthood. According to estimations, eight per cent of children and adolescents worldwide suffer with ADHD. The most prevalent type is the inattentive one, which is followed by the mixed and hyperactive/impulsive types. Compared to girls, boys are about twice as likely to be diagnosed with ADHD.
ADHD symptoms persist into adolescence and adulthood in approximately 30 to 50 per cent of individuals. As per the Fifth Diagnostic and Statistical Manual of Mental Disorders (DSM5), the core feature of ADHD is a collection of behaviours that hinder social status. Some of these social circumstances include excessive wobbling, talkativeness, finger play, and increased motor activity in inappropriate contexts, which can disrupt both personal and educational lives. The boys are more probable than girls to be suffering from attention deficit disorder, and its effects vary by age and gender.
In general, impulsivity, attention deficit, and hyperactivity are the hallmarks of ADHD. An individual who struggles with inattention may find it difficult to stay organized, focused, and on task. A person who is hyperactive may seem to move around a lot or fidget a lot.
People who are impulsive may act without thinking or have trouble controlling themselves. Individuals could act irresponsibly or lack the ability to give close attention to details when completing responsibilities like jobs, coursework, or other activities. To better understand these behavioural manifestations, it is essential to explore the neurological and biological underpinnings that shape the ADHD experience.
Esta historia es de la edición November 27, 2025 de Chronicle Pharmabiz.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Chronicle Pharmabiz
Chronicle Pharmabiz
Home-grown CAR-T cell therapies gaining ground
INDIAN biotech and pharmaceutical companies are actively working on innovative solutions to make CART cell therapy both accessible and cost-effective.
4 mins
November 27, 2025
Chronicle Pharmabiz
NPPA extends price fixation on orthopaedic implants for 1 year
IN a move that will disappoint the industry, the National Pharmaceutical Pricing Authority (NPPA) has extended the ceiling price fixation it imposed on orthopaedic knee implants for knee replacement system for one more year.
1 mins
November 27, 2025
Chronicle Pharmabiz
FICCI envisages it's Smart AAMs to boost healthcare
In line with the Central Government's vision of comprehensive primary healthcare, FICCI Swasth Bharat Task Force has undertaken a transformative initiative titled 'Smart Ayushman Arogya Mandirs-AAMs' (earlier called Health & Wellness Centres) aimed at strengthening the primary healthcare delivery system across India.
1 min
November 27, 2025
Chronicle Pharmabiz
DoP asked to bring policy for affordable drug pricing
THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DoP) to take steps to come out with a pharmaceutical policy with thrust to provide both scheduled and nonscheduled formulations at affordable prices.
1 mins
November 27, 2025
Chronicle Pharmabiz
Ramaiah emphasises need for bone health and osteoporosis diagnosis
RAMAIAH Memorial Hospital (RMH), a multi-superspecialty quaternary care hospitals emphasises on bone health and osteoporosis diagnosis. It calls for timely screening and diagnosis through the new and advanced DXA scanner with superior and accurate test results.
2 mins
November 27, 2025
Chronicle Pharmabiz
Nathealth calls for action in 2026-27 Union Budget
NATHEALTH has submitted its budget 2026-27 recommendations to the Union government, outlining a roadmap to strengthen healthcare delivery, foster innovation, and expand insurance and preventive coverage.
1 mins
November 27, 2025
Chronicle Pharmabiz
Hotspots & growth opportunities in biomanufacturing
THE Indian bioeconomy has grown from US$ 10 billion in 2014 to US$ 165.7 billion in 2024, and is likely reach US$ 300 billion by 2030.
3 mins
November 27, 2025
Chronicle Pharmabiz
Omega Hospitals acquires Cytecare Hospitals
Morgan Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.
2 mins
November 27, 2025
Chronicle Pharmabiz
Devices sector hails withdrawal of QCOs
THE medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.
1 min
November 27, 2025
Chronicle Pharmabiz
'There is urgent need for tech-focused regulatory approach for med devices'
THE Indian healthcare industry has evolved at a breakneck pace, but its regulatory framework has struggled to keep up to its speed of development.
2 mins
November 27, 2025
Listen
Translate
Change font size
